In bioinformatic analyses, ACAT1’s inhibitory effect on gastric cancer may be related to the Adipocytokine Signaling Pathway, the Ppar Signaling Pathway, propanoate metabolism, and the P53 Signaling Pathway. The gene discussed is PPARA; the disease is gastric cancer.